Digest Network Come funziona
Network
/
Società
Cl
Non verificato

ClearNote Health

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

15 comunicati stampa

Guarda tutti i comunicati
29/04/2026
Eventi
Industria
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
15/04/2026
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
ClearNote Health to Showcase Industry-Leading Early Detection Performance of the Avantect® Pancreatic Cancer Test at AACR Annual Meeting 2026
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
18/03/2026
Sanità
Salute
Scienza
Mercato del lavoro
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
23/02/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
17/10/2025
Scienza
Oncologia
Tecnica
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Eventi
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Biotecnologia
Sanità
Attrezzature medico-sanitarie
Salute
Oncologia
ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
09/07/2025
Oncologia
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
16/06/2025
Oncologia
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
23/04/2025
Eventi
Industria
Tecnica
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
ClearNote Health to Showcase Latest Advancements in Tumor Subtyping and Circulating Tumor Fraction Technologies at AACR Annual Meeting 2025
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0
12/03/2025
Mercato del lavoro
Industria
Software
Sanità
Associazioni/Professionisti
Oncologia
Tecnica
Biotecnologia
Salute
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks
Fonte
ClearNote Health
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0